Meta-analysis shows reduced prosthetic joint infection rates in total joint arthroplasty with an antimicrobial solution, suggesting improved outcomes.
Prosthetic joint infection (PJI) in the setting of total joint arthroplasty represents significant morbidity and economic burden to patients and the healthcare system. We analyzed a non-toxic, no-rinse intraoperative antimicrobial irrigation solution (AIS) that was designed to combat infection. In this meta-analysis of three studies, the AIS rate of PJI was 0.727 per 1000 surgeries (95% CI: [0.041, 3.19]), which was significantly less than the standard of care (SOC) rate of infection of 4.854 per 1000 (95% CI: [1.178, 27.73]) (p=0.045). This corresponds to a reduction of 85% in the odds of PJI (p = 0.045, 95% CI: [24%, 99%]). When compared to the American Association of Hip and Knee Surgeons (AAHKS) estimate of 1 infection per 100 surgeries, the AIS rate of infection was significantly less (p=0.004). The use of this AIS intraoperatively represents an efficient and effective technique to combat PJI in the setting of total joint arthroplasty.
No takes yet. Share an insight, caveat, or question.
Amin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: